GPR17 and neoplasm: On days 15 and 30 posttransplantation, we carried out luminescent imaging and observed a dramatically and consistently suppressed tumor formation in the BALB/c nude mice with U87-GPR17 cells, compared to the mice injected with U87-Vec cells (Fig. 1H).